ANIMAL RESOURCES FACILITY EQUIPMENT IMPROVED PROJECT
动物资源设施设备改造工程
基本信息
- 批准号:6758759
- 负责人:
- 金额:$ 65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-04-15 至 2006-04-14
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant):
The Joslin Diabetes Center is committed to the continued improvement of its animal care and use program. Recently completed renovations have greatly improved animal care by providing improvements in the physical plant, cage wash capabilities and animal housing. The addition of a full time Veterinarian Director has also strengthened the program, especially with regards to animal health, protocol development and fiscal stability. This improvement project will support the efforts of the Joslin Diabetes Center to continue the process of providing investigators with a quality research resource by enhancing animal welfare and the efficient operation of the animal facility. The described aims request additional PIV mouse racks, upgrading static murine micro-isolation cages, a full micro-isolation system for rats, a water purification system for all drinking water, and a laminar flow work station for a procedure room. Rats and mice are the only species housed in the Joslin Diabetes Center animal facility and the above improvements will impact their welfare by providing greater biosecurity, higher quality water, a healthier microenvironment for the animals and macrooenvironment for personnel, and static cages which allow animals to be more easily monitored. Aggressive pursuit of the short-term goals of improving animal care is critical to achieving the long-term goal of AAALAC; International accreditation. The research program at the Joslin Diabetes Center has experienced significant expansion and is expected to continue this trend due to the current epidemic of Type II diabetes. Animal models, primarily murine, have been enormously expanded as a result of the powerful tools of transgenic and knockout technologies. Not only will the requested improvements impact animal welfare, but they will also benefit the efficiency of the research animal program.
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GEORGE L KING其他文献
GEORGE L KING的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GEORGE L KING', 18)}}的其他基金
A pilot clinical trial to assess feasibility, facilitators and barriers of continuous glucose monitoring in Asian Americans with type 2 diabetes
一项试点临床试验,旨在评估患有 2 型糖尿病的亚裔美国人进行连续血糖监测的可行性、促进因素和障碍
- 批准号:
10511276 - 财政年份:2022
- 资助金额:
$ 65万 - 项目类别:
A pilot clinical trial to assess feasibility, facilitators and barriers of continuous glucose monitoring in Asian Americans with type 2 diabetes
一项试点临床试验,旨在评估患有 2 型糖尿病的亚裔美国人进行连续血糖监测的可行性、促进因素和障碍
- 批准号:
10709518 - 财政年份:2022
- 资助金额:
$ 65万 - 项目类别:
Characterization of cardiovascular diseases (CVD) in people with long duration Type 1 diabetes
长期 1 型糖尿病患者心血管疾病 (CVD) 的特征
- 批准号:
10543994 - 财政年份:2021
- 资助金额:
$ 65万 - 项目类别:
Characterization of cardiovascular diseases (CVD) in people with long duration Type 1 diabetes
长期 1 型糖尿病患者心血管疾病 (CVD) 的特征
- 批准号:
10372462 - 财政年份:2021
- 资助金额:
$ 65万 - 项目类别:
Pyruvate kinase M2 levels and activation as protective factors for diabetic nephropathy
丙酮酸激酶 M2 水平和激活作为糖尿病肾病的保护因素
- 批准号:
9235747 - 财政年份:2016
- 资助金额:
$ 65万 - 项目类别:
Characterization of Retinoid-Binding Protein 3 (RBP3): A Protective Factor Against Diabetic Retinopathy Identified in People with Extreme Diabetes Duration
类视黄醇结合蛋白 3 (RBP3) 的表征:在患有极度糖尿病病程的人群中发现的针对糖尿病视网膜病变的保护因子
- 批准号:
10320034 - 财政年份:2016
- 资助金额:
$ 65万 - 项目类别:
Characterization of Retinoid-Binding Protein 3 (RBP3): A Protective Factor Against Diabetic Retinopathy Identified in People with Extreme Diabetes Duration
类视黄醇结合蛋白 3 (RBP3) 的表征:在患有极度糖尿病病程的人群中发现的针对糖尿病视网膜病变的保护因子
- 批准号:
10543746 - 财政年份:2016
- 资助金额:
$ 65万 - 项目类别:
Identification of Retinoid-Binding Protein 3 (RBP3): A Protective Factor against Diabetic Retinopathy Using Retina from People with Extreme Duration of Diabetes
类维生素A结合蛋白3 (RBP3)的鉴定:利用糖尿病病程极长的人的视网膜来鉴定糖尿病视网膜病变的保护因子
- 批准号:
9006846 - 财政年份:2016
- 资助金额:
$ 65万 - 项目类别:
Validation of Potential Protective Factors from Diabetic Complications
验证糖尿病并发症的潜在保护因素
- 批准号:
8922182 - 财政年份:2011
- 资助金额:
$ 65万 - 项目类别:
Validation of Potential Protective Factors from Diabetic Complications
验证糖尿病并发症的潜在保护因素
- 批准号:
8241364 - 财政年份:2011
- 资助金额:
$ 65万 - 项目类别:
相似海外基金
Renovation of Temple's Psychology Department Animal Colony
天普心理系动物群改造
- 批准号:
9602717 - 财政年份:1997
- 资助金额:
$ 65万 - 项目类别:
Standard Grant